[HTML][HTML] Could oxidative stress play a role in the development and clinical management of differentiated thyroid cancer?

M Kościuszko, A Buczyńska, AJ Krętowski… - Cancers, 2023 - mdpi.com
Simple Summary Increased oxidative stress (OS) has been implicated as a relevant risk
factor for cancer development and progression. The incidence of differentiated thyroid …

[HTML][HTML] Molecular features of aggressive thyroid cancer

G Elia, A Patrizio, F Ragusa, SR Paparo… - Frontiers in …, 2022 - frontiersin.org
Poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC) have a
worse prognosis with respect to well differentiated TC, and the loss of the capability of up …

[HTML][HTML] The role of the kinase inhibitors in thyroid cancers

F Cuomo, C Giani, G Cobellis - Pharmaceutics, 2022 - mdpi.com
Thyroid cancer is the most common endocrine malignancy, accounting for about 3% of all
cancer cases each year worldwide with increasing incidence, but with the mortality …

[HTML][HTML] Multi-omics and management of follicular carcinoma of the thyroid

TE Luvhengo, I Bombil, A Mokhtari, MS Moeng… - Biomedicines, 2023 - mdpi.com
Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland,
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …

[HTML][HTML] Rationale efficacy and safety evidence of Lenvatinib and Pembrolizumab Association in anaplastic thyroid carcinoma

L Boudin, JB Morvan, J Thariat, D Métivier, PY Marcy… - Current …, 2022 - mdpi.com
Anaplastic thyroid carcinoma (ATC) are highly aggressive malignant tumors with poor
overall prognosis despite multimodal therapy. As ATC are extremely rare, no randomized …

[HTML][HTML] Normal and neoplastic growth suppression by the extended myc network

EV Prochownik, H Wang - Cells, 2022 - mdpi.com
Among the first discovered and most prominent cellular oncogenes is MYC, which encodes
a bHLH-ZIP transcription factor (Myc) that both activates and suppresses numerous genes …

New insights into immune cells and immunotherapy for thyroid cancer

Y Tao, P Li, C Feng, Y Cao - Immunological Investigations, 2023 - Taylor & Francis
Thyroid cancer (TC) is the most common endocrine malignancy worldwide, and the
incidence of TC has gradually increased in recent decades. Differentiated thyroid cancer …

[HTML][HTML] Metabolic profile characterization of different thyroid nodules using FTIR spectroscopy: a review

V Neto, S Esteves-Ferreira, I Inacio, M Alves, R Dantas… - Metabolites, 2022 - mdpi.com
Thyroid cancer's incidence has increased in the last decades, and its diagnosis can be a
challenge. Further and complementary testing based in biochemical alterations may be …

Functional loss of tumor suppressor genes detected by loss of heterozygosity, but not driver mutations, predicts aggressive lymph node status in papillary thyroid …

S Finkelstein, VA Timmaraju, S Samankan… - … -Research and Practice, 2023 - Elsevier
Background Recognizing aggressive tumor biology is essential to optimizing patient
management for papillary thyroid carcinomas (PTC). Aggressive lymph node (ALN) status is …

BUB1/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability

T Jin, L Ding, J Chen, X Zou, T Xu… - Journal of Cellular …, 2024 - Wiley Online Library
Chromosome instability (CIN) is a common contributor driving the formation and progression
of anaplastic thyroid cancer (ATC), but its mechanism remains unclear. The BUB1 mitotic …